MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
Anoek S Van Vugt, Josjan Zijlmans, Ramon Lindauer, Levi Van Dam
Drug Science, Policy and Law January 1, 2023 DOI: 10.1177/20503245231198477
Summary
AI-generated from the abstractAdolescents, parents, and clinicians initially held unfavorable views of MDMA, but after a standardized explanation of MDMA-assisted psychotherapy, all but one participant supported exploring this treatment for adolescents with PTSD. The study used focus groups with 9 trauma-exposed adolescents and young adults, 4 parents of traumatized children, and 6 trauma clinicians. All groups emphasized the need for further research before clinical trials. The findings suggest that providing clear information can shift attitudes toward openness to MDMA-assisted psychotherapy as a potential treatment for adolescent PTSD.
Study at a glance
| Characteristics | Qualitative study with focus groups Peer reviewed |
|---|---|
| Sample size | 19 |
| Population | Adolescents and young adults (16-24 years old) who had undergone trauma therapy, parents of traumatized children, and trauma clinicians |
| Citations | 2 |
| Key finding | After receiving a standardized explanation of MDMA-assisted psychotherapy, adolescents, parents, and clinicians largely shifted from unfavorable to supportive attitudes toward exploring this treatment for adolescents with PTSD, while emphasizing the need for prior research. |
Abstract
Background PTSD in adolescence causes much suffering and has substantial health-care costs. Many patients with severe PTSD do not respond to psychotherapy or continue to have symptoms despite trauma-focused psychotherapies and psychopharmacological treatment. A recent alternative in the search for cost-effective treatments for PTSD in adults is 3,4-methylenedioxymethamphetamine-assisted psychotherapy (MDMA-assisted psychotherapy). However, no research has yet been conducted on the therapeutic potential of MDMA for adolescents. Aims of the study The purpose of this study is to investigate the perspectives of adolescents, parents, and clinicians about the possible clinical application of MDMA-assisted psychotherapy for adolescents with PTSD. Method We performed focus groups in three samples: (a) 16–24-year-olds who had undergone trauma therapy ( N = 9), (b) parents of traumatized children ( N = 4), and (c) trauma clinicians ( N = 6). Focus group topics included: perception of and associations with MDMA, opinions on MDMA-assisted psychotherapy, risks/benefits, and precautions to take prior to possible adolescent clinical trials with MDMA-assisted psychotherapy. Results In all groups, initial participant attitudes towards MDMA were predominantly unfavorable, except for several adolescents who had conducted preliminary research on the subject. After a standardized explanation of MDMA-assisted psychotherapy, provided in each group, all but one participant changed their minds and supported the idea of implementing MDMA-assisted psychotherapy for adolescents. They all emphasized the importance of conducting research first. Conclusion Our findings suggest that when provided with information on what MDMA-assisted psychotherapy entails, adolescents, parents, and clinicians are open to the idea of exploring this type of treatment for adolescents.